+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "GABAB Agonist"

GABAB Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

GABAB Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

GABAB agonists are a class of drugs used to treat a variety of conditions related to the central nervous system. These drugs act on the GABAB receptor, a type of neurotransmitter receptor found in the brain, to produce a calming effect. GABAB agonists are used to treat anxiety, depression, epilepsy, and other neurological disorders. They are also used to treat alcohol and drug addiction, as well as to reduce the symptoms of Parkinson's disease. GABAB agonists are generally considered to be safe and effective treatments for these conditions. However, they can cause side effects such as drowsiness, dizziness, and nausea. As with any medication, it is important to discuss the potential risks and benefits with a healthcare provider before starting treatment. Some companies in the GABAB agonist market include AbbVie, Allergan, AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more